Skip to main content

Diagnostic options · UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 571–585 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2779
OncoPro EGFR Rapid Test

This test detects specific mutations in the EGFR gene from FFPE tumor tissue using real-time PCR.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block – Archival Specimen Next working day (specimen received by 11:00 AM) 2,000.00 AED
View
View test specifications and preparation
What it measures
["EGFR gene mutations (exon 19 deletions, L858R, T790M, and others)", "Actionable mutations in NSCLC"]
Parameters
[{"name": "Sensitivity", "reference_range": "99.9%"}, {"name": "Specificity", "reference_range": "99.8%"}]
Preparation
["No preparation or fasting is required."]
Indications
["Diagnosis of Non-Small Cell Lung Cancer (NSCLC)", "Guiding targeted therapy decisions", "Monitoring treatment response and resistance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-4 ICD-10: C34.90, C34.1, Z15.09
Clinical summary
This test detects specific mutations in the EGFR gene from FFPE tumor tissue using real-time PCR.
TEST-2810
OncoPro Focus Fusion Panel for Solid Tumors Test

This test detects clinically actionable gene fusions in solid tumors using next-generation sequencing.

FFPE tumour block (archival solid tissue) 15 working days from sample receipt 4,600.00 AED
View
View test specifications and preparation
What it measures
["Gene fusions", "Actionable genomic alterations"]
Parameters
[]
Preparation
["No special patient preparation is needed"]
Indications
["Diagnosis of solid tumors", "Guidance for targeted therapy selection", "Prognosis prediction", "Monitoring treatment resistance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92878-8 ICD-10: C80.9
Clinical summary
This test detects clinically actionable gene fusions in solid tumors using next-generation sequencing.
TEST-2815
ONCOPRO Hereditary Cancer Risk Panel (200 Genes) Test

This test evaluates 200 genes associated with hereditary cancer syndromes using Next-Generation Sequencing.

Whole Blood (Peripheral Blood, EDTA) 35 working days 3,700.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic and likely pathogenic variants in 200 cancer-related genes", "Coding regions and splice sites of analysed genes"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of recent blood transfusions (within 2 weeks)"]
Indications
["Individuals with a personal or family history suggestive of hereditary cancer syndrome", "Risk assessment for individuals with specific cancer types", "Guiding personalised cancer screening and prevention strategies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 102876-0 ICD-10: Z15.01, Z15.02, Z15.09
Clinical summary
This test evaluates 200 genes associated with hereditary cancer syndromes using Next-Generation Sequencing.
TEST-2788
ONCOPRO KRAS Rapid Test

This test detects specific mutations in the KRAS gene within tumor tissue to guide targeted cancer therapy decisions.

Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block Next working day (sample received by 11 AM) 2,000.00 AED
View
View test specifications and preparation
What it measures
["KRAS gene mutations (codons 12, 13, 61, 146)", "Variant Allele Frequency (VAF)"]
Parameters
[{"name": "Precision (Analytical Sensitivity)", "reference_range": "99.9% – Detects mutant alleles at ≤1% VAF"}, {"name": "Methodology", "reference_range": "Real-Time PCR (qPCR)"}, {"name": "Tissue Requirement", "reference_range": "FFPE block with ≥10% tumor tissue"}]
Preparation
[]
Indications
["Metastatic colorectal cancer", "Non-small cell lung cancer", "Pancreatic ductal adenocarcinoma"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21702-3 ICD-10: C18.9, Z15.09, C25.9
Clinical summary
This test detects specific mutations in the KRAS gene within tumor tissue to guide targeted cancer therapy decisions.
TEST-2817
OncoPro Liquid Biopsy Test

This test analyzes circulating tumor DNA (ctDNA) in a blood sample using Next Generation Sequencing (NGS) to provide a genomic profile for cancer management.

Whole Blood 35 working days 21,500.00 AED
View
View test specifications and preparation
What it measures
["Circulating Tumor DNA (ctDNA)", "Genomic Mutations"]
Parameters
[]
Preparation
[]
Indications
["Guiding targeted cancer therapy", "Monitoring treatment response", "Cancer diagnosis (in specific contexts)", "Patients with confirmed cancer diagnosis or strong clinical suspicion"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94420-0 ICD-10: Z08.0
Clinical summary
This test analyzes circulating tumor DNA (ctDNA) in a blood sample using Next Generation Sequencing (NGS) to provide a genomic profile for cancer management.
TEST-57
Oncopro Pan Cancer Monitor Test

This test detects and characterizes circulating tumour cells (CTCs) in peripheral blood using immunocytochemistry and AI-driven morphometry.

Peripheral whole blood 21 Days 3,300.00 AED
View
View test specifications and preparation
What it measures
["Circulating Tumour Cells (CTCs)", "Multi-phenotype analysis"]
Parameters
[{"name": "Circulating Tumour Cells (CTCs)", "reference_range": null}]
Preparation
["No fasting required"]
Indications
["Early recurrence surveillance", "Therapy-response tracking", "Monitoring minimal residual disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88297-3 ICD-10: Z08.0
Clinical summary
This test detects and characterizes circulating tumour cells (CTCs) in peripheral blood using immunocytochemistry and AI-driven morphometry.
TEST-54
OncoPro PD‑L1 Circulating Tumor Cells Test

This test quantifies PD‑L1 protein expression on circulating tumor cells (CTCs) isolated from a blood sample.

8 mL whole blood in EDTA preservative tube 21 working days 5,900.00 AED
View
View test specifications and preparation
What it measures
["PD‑L1 protein expression", "Circulating Tumor Cells (CTCs)"]
Parameters
[]
Preparation
["No fasting required", "Avoid refrigerating or freezing the sample"]
Indications
["Guiding immunotherapy decisions for lung, breast, and urothelial cancers", "Predicting response to immune checkpoint inhibitors"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96314-1 ICD-10: C34.9
Clinical summary
This test quantifies PD‑L1 protein expression on circulating tumor cells (CTCs) isolated from a blood sample.
TEST-62
OncoPro Prostate Cancer Screening Test

This test detects circulating tumor cells (CTCs) in whole blood to assess prostate cancer risk with high specificity.

Whole blood (8 mL) 21 Working Days 3,200.00 AED
View
View test specifications and preparation
What it measures
["Circulating tumor cells (CTCs)", "Molecular-level risk profiling"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications without consulting your physician"]
Indications
["Prostate cancer screening", "Risk stratification in men with elevated PSA", "Reducing unnecessary biopsies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 85309-6 ICD-10: Z12.5
Clinical summary
This test detects circulating tumor cells (CTCs) in whole blood to assess prostate cancer risk with high specificity.
TEST-2797
OncoPro Tumor Mutation Burden (TMB) Test

This test quantifies the number of somatic mutations within a tumor's DNA, providing insight into potential response to immunotherapy.

FFPE tissue block 15 working days 7,800.00 AED
View
View test specifications and preparation
What it measures
["Somatic mutations per megabase (mut/Mb)", "Tumor mutational load"]
Parameters
[{"name": "Tumor Mutation Burden (TMB)", "reference_range": "≥10 mut/Mb (TMB-High)"}]
Preparation
[]
Indications
["Predictive biomarker for immune checkpoint inhibitor therapy", "Metastatic solid tumors"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86900-0 ICD-10: C80.1, Z85.9
Clinical summary
This test quantifies the number of somatic mutations within a tumor's DNA, providing insight into potential response to immunotherapy.
TEST-3643
OPTN Gene Glaucoma (Open-Angle Type 1E) Test

This genetic test evaluates the OPTN gene for variants associated with hereditary open-angle glaucoma type 1E.

Whole Blood 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["OPTN gene variants", "Cellular waste clearance (autophagy)", "Intraocular pressure regulation"]
Parameters
[]
Preparation
[]
Indications
["Individuals with a personal or family history of open-angle glaucoma type 1E.", "Patients requiring genetic risk stratification for glaucoma.", "Family cascade screening for relatives of affected individuals."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93823-1 ICD-10: H40.11
Clinical summary
This genetic test evaluates the OPTN gene for variants associated with hereditary open-angle glaucoma type 1E.
TEST-28
Oxford Nanopore Long‑Read Sequencing (1 GB) Test

This test provides a comprehensive analysis of the entire genome using long-read sequencing technology. It identifies structural variants, epigenetic modifications, and other compl...

Whole blood (EDTA) – 6 mL, or extracted DNA (10 ng/μL min) 4 weeks from sample receipt 8,500.00 AED
View
View test specifications and preparation
What it measures
["Structural variants (deletions, duplications, inversions)", "Repeat expansions", "Methylation patterns", "Haplotype phasing", "Single-nucleotide variants"]
Parameters
[]
Preparation
[]
Indications
["Research purposes", "Anti-aging strategies", "Clinical genetic diagnosis", "Personalized medicine", "Preventive healthcare planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Z00.8
Clinical summary
This test provides a comprehensive analysis of the entire genome using long-read sequencing technology. It identifies structural variants, epigenetic modifications, and other complex genomic features.
TEST-33
Oxford Nanopore Sequencing (Flow Cell) Test

This test provides a comprehensive analysis of the genome using long-read sequencing technology.

Whole blood (6 mL EDTA) or extracted DNA (minimum 5 µg) 2 weeks 35,000.00 AED
View
View test specifications and preparation
What it measures
["Whole Genome Sequence", "Structural Variants", "Repeat Expansions", "Epigenetic Modifications"]
Parameters
[]
Preparation
[]
Indications
["Anti-aging optimization", "Rare disease diagnosis", "Pharmacogenomics", "Detection of structural variants", "Detection of repeat expansions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78063-6 ICD-10: Z13.7
Clinical summary
This test provides a comprehensive analysis of the genome using long-read sequencing technology.
TEST-213
PacBio Sequel II Library Preparation Test

This test prepares DNA for long-read sequencing, generating SMRTbell libraries optimized for the PacBio Sequel II instrument.

Whole Blood (5 mL in K2EDTA tube) 20 Business Days 12,500.00 AED
View
View test specifications and preparation
What it measures
["DNA quality", "Library yield", "Fragment size distribution"]
Parameters
[{"name": "Library Yield", "reference_range": null}, {"name": "Fragment Size Distribution", "reference_range": null}, {"name": "Sequencing-Ready Certification", "reference_range": null}]
Preparation
["No fasting required", "Hydrate normally", "Have Emirates ID ready"]
Indications
["Detection of structural variants", "Epigenetic modifications analysis", "Complex genomic rearrangements investigation", "Research purposes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51960-2 ICD-10: Z13.89
Clinical summary
This test prepares DNA for long-read sequencing, generating SMRTbell libraries optimized for the PacBio Sequel II instrument.
TEST-24
PacBio Sequel II Long-Read Whole Genome Sequencing (30 Gb) Test

This test provides a comprehensive analysis of the entire genome using long-read sequencing technology.

Whole blood (K2EDTA) or high-quality extracted DNA (≥1 µg, >50 ng/µL) 4 weeks from sample receipt 30,000.00 AED
View
View test specifications and preparation
What it measures
["Structural variants", "Repetitive elements", "Epigenetic modifications", "Mitochondrial genome integrity", "Tandem repeat expansions"]
Parameters
[]
Preparation
[]
Indications
["Anti-aging medicine", "Preventive genomic medicine", "Understanding biological aging"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92574-0 ICD-10: Z13.89
Clinical summary
This test provides a comprehensive analysis of the entire genome using long-read sequencing technology.
TEST-651
Pan Fungal (RNA Detection) Qualitative Test

This test detects the presence of RNA from a wide range of fungal pathogens in blood, tissue, or respiratory specimens.

Blood, Tissue, or Respiratory Specimen 36–48 hours 750.00 AED
View
View test specifications and preparation
What it measures
["Fungal RNA", "Presence of specific fungal genera (Aspergillus, Candida, Mucorales, rare moulds)"]
Parameters
[]
Preparation
["No fasting or dietary restrictions are needed.", "Provide a signed consent form and detailed clinical history including current medications."]
Indications
["Suspected invasive fungal infection", "Immunocompromised patients", "Failure to respond to empirical antifungal therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60571-3 ICD-10: B49
Clinical summary
This test detects the presence of RNA from a wide range of fungal pathogens in blood, tissue, or respiratory specimens.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area